Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.0000769 per share
-
Shares outstanding
-
45,504,462
-
Total 13F shares
-
2,830,846
-
Share change
-
-220,181
-
Total reported value
-
$3,283,550
-
Put/Call ratio
-
11%
-
Price per share
-
$1.16
-
Number of holders
-
9
-
Value change
-
-$215,426
-
Number of buys
-
1
-
Number of sells
-
6
Institutional Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q1 2023
As of 31 Mar 2023,
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,830,846 shares.
The largest 8 holders included
Knoll Capital Management, LLC, RA CAPITAL MANAGEMENT, L.P., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, PNC Financial Services Group, Inc., UBS Group AG, JPMORGAN CHASE & CO, and MORGAN STANLEY.
This page lists
8
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.